POS-223 Clinical Utility of KidneyIntelX in Patients with Early Stages of Diabetic Kidney Disease in CANVAS Participants

• D. Lam,
• G. Nadkarni,
• B. Neal,
• K. Mahaffey,
• N. Rosenthal,
• M. Hansen,
• S. COCA,
• H. Heerspink

Affiliations

D. Lam

Icahn School of Medicine at Mount Sinai, Medicine/Endocrinology, New York, United States

G. Nadkarni

Icahn School of Medicine at Mount Sinai, Medicine/Nephrology, New York, United States

B. Neal

The George Institute for Global Health, Medicine, Sydney, Australia

K. Mahaffey

Stanford Center for Clinical Research, Medicine, Stanford, United States

N. Rosenthal

Janssen, Research and Development, Spring House, United States

M. Hansen

Janssen, Research and Development, Spring House, United States

S. COCA

Icahn School of Medicine at Mount Sinai, Medicine/Nephrology, New York, United States

H. Heerspink

University of Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, Netherlands